Cite
Leucine-Rich Alpha-2-Glycoprotein 1 is a Systemic Biomarker of Early Brain Injury and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.
MLA
Savarraj, Jude P. J., et al. “Leucine-Rich Alpha-2-Glycoprotein 1 Is a Systemic Biomarker of Early Brain Injury and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.” Neurocritical Care, vol. 38, no. 3, June 2023, pp. 771–80. EBSCOhost, https://doi.org/10.1007/s12028-022-01652-7.
APA
Savarraj, J. P. J., McBride, D. W., Park, E., Hinds, S., Paz, A., Gusdon, A., Xuefang, R., Pan, S., Ahnstedt, H., Colpo, G. D., Kim, E., Zhao, Z., McCullough, L., & Choi, H. A. (2023). Leucine-Rich Alpha-2-Glycoprotein 1 is a Systemic Biomarker of Early Brain Injury and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage. Neurocritical Care, 38(3), 771–780. https://doi.org/10.1007/s12028-022-01652-7
Chicago
Savarraj, Jude P. J., Devin W. McBride, Eunsu Park, Sarah Hinds, Atzhiry Paz, Aaron Gusdon, Ren Xuefang, et al. 2023. “Leucine-Rich Alpha-2-Glycoprotein 1 Is a Systemic Biomarker of Early Brain Injury and Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.” Neurocritical Care 38 (3): 771–80. doi:10.1007/s12028-022-01652-7.